More biotechs announce share buybacks; Cosette to buy Mayne Pharma

Plus, news about MeiraGTx, Hookipa and Poolbeg Pharma: A pair of $500M share buybacks: Exelixis and Neurocrine Biosciences each laid out plans to buy back half a ...

Related Posts

Comments

Name

Email

Comment

Post Comment